Project Grant HT94252510613
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $794K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Evanston, IL 60208, USA
Similar Awards
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $158,254.00 to the University of Illinois to support a research project titled "DUAL CRE/LOX AND LENTIVIRAL CRISPR/CAS9 SYSTEM FOR PRECISE IN VIVO DISSECTION OF GBM AND MICROENVIRONMENT INTERACTION." The project aims to advance scientific understanding and treatment of glioblastoma (GBM) by developing innovative genetic technologies for in...
- This Project Grant award of $1,594,419.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by The Regents of the University of California, San Francisco (UCSF) on "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The research aims to develop innovative diagnostic and treatment approaches for a specific type of brain cancer through advanced biomedical investigations. This...
- This federal Project Grant award of $158,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a genetically engineered mouse model of spinal ependymoma precursors in NF2-related schwannomatosis. The project will be conducted by the Trustees of Indiana University, a prominent public research university, over a performance period from September 15, 2025 to August 14, 2027. The award aims to advance biomedical research...
- This $165,000 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Massachusetts General Hospital to map drug-sensitive gene expression profiles to spatial patterns of heterogeneity in a mouse model of schwannoma. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing scientific understanding and developing potential...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $557,592 to Northwestern University to conduct research on overcoming resistance in synovial sarcoma to interferon gamma-mediated immunosensitization. The research aims to transform healthcare for military service members and the broader public by developing innovative medical solutions to address critical health challenges. The award has a period of...
- This federal Project Grant award of $1,612,104.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Chicago to develop senescent tumor cell-loaded dendritic cell vaccines for breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The 3-year...
- The federal Project Grant award of $384,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Translational Genomics Research Institute (TGen) located in Phoenix, Arizona. The funding supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The project, titled "SINGLE: SIGNATURE ENABLING GLIOMA ENROLLMENT", will be performed from...
- This $1,626,438 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research conducted by the University of Texas MD Anderson Cancer Center (MD Anderson) to transform healthcare for military service members, veterans, and the general public. The research project, known as the "MCCAIN/BAYH GLIOBLASTOMA CONSORTIUM", will investigate innovative medical solutions for glioblastoma, an aggressive form of...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...